Search results

1 – 10 of 308
Expert briefing
Publication date: 30 July 2019

The US life sciences sector.

Details

DOI: 10.1108/OXAN-DB245498

ISSN: 2633-304X

Keywords

Geographic
Topical
Expert briefing
Publication date: 11 September 2017

The Argentine health sector.

Details

DOI: 10.1108/OXAN-DB224345

ISSN: 2633-304X

Keywords

Geographic
Topical
Expert briefing
Publication date: 30 July 2020

It is now known which groups are more vulnerable and there is a good appreciation of case numbers in high-income countries. Knowledge about how the virus is transmitted is still…

Details

DOI: 10.1108/OXAN-DB254239

ISSN: 2633-304X

Keywords

Geographic
Topical
Expert briefing
Publication date: 25 March 2020

Headwinds for US-ASEAN trade.

Expert briefing
Publication date: 18 August 2020

Significant time and resources have been diverted towards the COVID-19 response effort, with unparalleled levels of funding and collaboration. The initial focus has been on the…

Details

DOI: 10.1108/OXAN-DB254642

ISSN: 2633-304X

Keywords

Geographic
Topical
Expert briefing
Publication date: 6 March 2018

Cancer advances.

Details

DOI: 10.1108/OXAN-DB230203

ISSN: 2633-304X

Keywords

Geographic
Topical
Expert briefing
Publication date: 15 February 2017

HIV and AIDS have slipped from the public radar in recent years but nonetheless remains a serious health challenge across sub-Saharan Africa (SSA). Efforts to control the epidemic…

Details

DOI: 10.1108/OXAN-DB217981

ISSN: 2633-304X

Keywords

Geographic
Topical
Expert briefing
Publication date: 23 February 2016

Latin America's most serious health challenge -- obesity.

Expert briefing
Publication date: 21 February 2024

Demand for the company's type 2 diabetes treatment, Ozempic, and its higher-dose version, Wegovy, has surged since November when the US Food and Drug Administration (FDA) approved…

Details

DOI: 10.1108/OXAN-DB285358

ISSN: 2633-304X

Keywords

Geographic
Topical
Expert briefing
Publication date: 9 April 2021

Government authorities, including in the United States, are speeding up licensing for clinical trials of these controlled drugs. Substantial philanthropic funding supports…

1 – 10 of 308